Defense Health Board (DHB) Meeting, 8064 [E9-3767]
Download as PDF
<![CDATA[
8064
Federal Register / Vol. 74, No. 34 / Monday, February 23, 2009 / Notices
high purity beryllium to the
Department.
Recognizing that high purity
beryllium meets all the conditions for
being a critical material, the Department
should take, and has taken, special
action to maintain a domestic supply.
The Department has used the authorities
of Title III of the Defense Production Act
to contract with U.S. firm BrushWellman, Inc. to build and operate a
new high purity beryllium production
plant. The new facility will produce
pure beryllium capable of meeting the
specifications required for myriad
national security applications.
Dated: February 6, 2009.
Patricia L. Toppings,
OSD Federal Register Liaison Officer,
Department of Defense.
[FR Doc. E9–3708 Filed 2–20–09; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Defense Health Board (DHB) Meeting
Department of Defense (DoD).
Notice of meeting.
AGENCY:
ACTION:
SUMMARY: Pursuant to the Federal
Advisory Committee Act of 1972 (5
U.S.C., Appendix as amended), the
Sunshine in the Government Act of
1976 (5 U.S.C. 552b, as amended), and
41 CFR 102–3.150, and in accordance
with section 10(a)(2) of Public Law, the
following meeting of the Defense Health
Board (DHB) is announced.
DATES: March 9–10, 2009.
jlentini on PROD1PC65 with NOTICES
March 9, 2009
7 a.m.–12 p.m. (Open Session).
12 p.m.–2:15 p.m. (Administrative
Working Meeting).
2:15 p.m.–5:15 p.m. (Open Session).
March 10, 2009
8 a.m.–4:30 p.m. (Administrative
Working Meeting).
ADDRESSES: Flagler Ballroom, Marriott
Beachside Hotel, 3841 North Roosevelt
Boulevard, Key West, Florida 33040.
FOR FURTHER INFORMATION CONTACT:
Commander Edmond F. Feeks,
Executive Secretary, Defense Health
Board, Five Skyline Place, 5111
Leesburg Pike, Suite 810, Falls Church,
Virginia 22041–3206, (703) 681–8448,
EXT. 1228, Fax: (703) 681–3317,
edmond.feeks@tma.osd.mil. Additional
information, agenda updates, and
meeting registration are available online
at the Defense Health Board Web site,
https://www.ha.osd.mil/dhb. The public
is encouraged to register for the meeting.
VerDate Nov<24>2008
16:31 Feb 20, 2009
Jkt 217001
If special accommodations are required
to attend (sign language, wheelchair
accessibility) please contact Ms. Lisa
Jarrett at (703) 681–8448 ext. 1280 by
February 27, 2009. Written statements
may be mailed to the above address, emailed to dhb@ha.osd.mil or faxed to
(703) 681–3317.
SUPPLEMENTARY INFORMATION:
Purpose of the Meeting: The purpose
of the meeting is to address and
deliberate pending and new Board
issues and provide briefings for Board
members on topics related to ongoing
Board business.
Agenda: On March 9, 2009, the Board
will receive briefings on military
operations worldwide and in the Key
West, Florida area. The following
Defense Health Board Subcommittees
will present updates to the Board: the
Department of Defense Joint Pathology
Center Work Group, the Task Force on
the Review of the Department of
Defense Biological Research Portfolio
and Biodefense Infrastructure, the
Psychological Health External Advisory
Subcommittee, the Trauma and Injury
Subcommittee, the Health Care Delivery
External Advisory Subcommittee, the
National Capital Region Base
Realignment and Closure
Subcommittee, and the Traumatic Brain
Injury Family Caregivers Panel. The
Board will also receive an informational
briefing on the use of apheresis platelets
and fresh whole blood in trauma
situations. The Board will conduct
administrative sessions in concert with
the meeting on March 9, 2009 and on
March 10, 2009. Pursuant to 41 Code of
Federal Regulations, Part 102–3.160, the
administrative working meetings are
closed to the public.
Pursuant to 5 U.S.C. 552b, as
amended, and 41 CFR 102–3.140
through 102–3.165 and subject
availability of space, the Defense Health
Board meeting from 7 a.m. to 12 p.m.
and from 2:15 p.m. to 5:15 p.m. on
March 9, 2009 is open to the public.
Any member of the public wishing to
provide input to the Defense Health
Board should submit a written
statement in accordance with 41 CFR
102–3.140(C) and section 10(a)(3) of the
Federal Advisory Committee Act, and
the procedures described in this notice.
Written statement should be not longer
than two type-written pages and must
address the following detail: The issue,
discussion, and a recommended course
of action. Supporting documentation
may also be included as needed to
establish the appropriate historical
context and to provide any necessary
background information.
PO 00000
Frm 00013
Fmt 4703
Sfmt 4703
Individuals desiring to submit a
written statement may do so through the
Board’s Designated Federal Officer at
the address detailed above at any point.
However, if the written statement is not
received at least 10 calendar days prior
to the meeting, which is subject to this
notice, then it may not be provided to
or considered by the Defense Health
Board until the next open meeting.
The Designated Federal Officer will
review all timely submissions with the
Defense Health Board Chairperson, and
ensure they are provided to members of
the Defense Health Board before the
meeting that is subject to this notice.
After reviewing the written comments,
the Chairperson and the Designated
Federal Officer may choose to invite the
submitter of the comments to orally
present their issue during an open
portion of this meeting or at a future
meeting.
The Designated Federal Officer, in
consultation with the Defense Health
Board Chairperson, may, if desired, allot
a specific amount of time for members
of the public to present their issues for
review and discussion by the Defense
Health Board.
Dated: February 17, 2009.
Patricia L. Toppings,
OSD Federal Register Liaison Officer,
Department of Defense.
[FR Doc. E9–3767 Filed 2–20–09; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
[Docket ID DOD–2009-OS–0025]
Privacy Act of 1974; Systems of
Records
AGENCY: Defense Finance and
Accounting Service, DoD.
ACTION: Notice to Amend a System of
Records.
SUMMARY: The Defense Finance and
Accounting Service (DFAS) is proposing
to amend a system of records notice in
its inventory of record systems subject
to the Privacy Act of 1974 (5 U.S.C.
552a), as amended.
DATES: This proposed action will be
effective without further notice on
March 25, 2009 unless comments are
received which would result in a
contrary determination.
ADDRESSES: Send comments to the
Defense Finance and Accounting
Service, FOIA/PA Program Manager,
Corporate Communications and
Legislative Liaison, 8899 E. 56th Street,
Indianapolis, IN 46249–0150.
E:\FR\FM\23FEN1.SGM
23FEN1
]]>Agencies
[Federal Register Volume 74, Number 34 (Monday, February 23, 2009)]
[Notices]
[Page 8064]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3767]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Defense Health Board (DHB) Meeting
AGENCY: Department of Defense (DoD).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: Pursuant to the Federal Advisory Committee Act of 1972 (5
U.S.C., Appendix as amended), the Sunshine in the Government Act of
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in
accordance with section 10(a)(2) of Public Law, the following meeting
of the Defense Health Board (DHB) is announced.
DATES: March 9-10, 2009.
March 9, 2009
7 a.m.-12 p.m. (Open Session).
12 p.m.-2:15 p.m. (Administrative Working Meeting).
2:15 p.m.-5:15 p.m. (Open Session).
March 10, 2009
8 a.m.-4:30 p.m. (Administrative Working Meeting).
ADDRESSES: Flagler Ballroom, Marriott Beachside Hotel, 3841 North
Roosevelt Boulevard, Key West, Florida 33040.
FOR FURTHER INFORMATION CONTACT: Commander Edmond F. Feeks, Executive
Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg
Pike, Suite 810, Falls Church, Virginia 22041-3206, (703) 681-8448,
EXT. 1228, Fax: (703) 681-3317, edmond.feeks@tma.osd.mil. Additional
information, agenda updates, and meeting registration are available
online at the Defense Health Board Web site, https://www.ha.osd.mil/dhb.
The public is encouraged to register for the meeting. If special
accommodations are required to attend (sign language, wheelchair
accessibility) please contact Ms. Lisa Jarrett at (703) 681-8448 ext.
1280 by February 27, 2009. Written statements may be mailed to the
above address, e-mailed to dhb@ha.osd.mil or faxed to (703) 681-3317.
SUPPLEMENTARY INFORMATION:
Purpose of the Meeting: The purpose of the meeting is to address
and deliberate pending and new Board issues and provide briefings for
Board members on topics related to ongoing Board business.
Agenda: On March 9, 2009, the Board will receive briefings on
military operations worldwide and in the Key West, Florida area. The
following Defense Health Board Subcommittees will present updates to
the Board: the Department of Defense Joint Pathology Center Work Group,
the Task Force on the Review of the Department of Defense Biological
Research Portfolio and Biodefense Infrastructure, the Psychological
Health External Advisory Subcommittee, the Trauma and Injury
Subcommittee, the Health Care Delivery External Advisory Subcommittee,
the National Capital Region Base Realignment and Closure Subcommittee,
and the Traumatic Brain Injury Family Caregivers Panel. The Board will
also receive an informational briefing on the use of apheresis
platelets and fresh whole blood in trauma situations. The Board will
conduct administrative sessions in concert with the meeting on March 9,
2009 and on March 10, 2009. Pursuant to 41 Code of Federal Regulations,
Part 102-3.160, the administrative working meetings are closed to the
public.
Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through
102-3.165 and subject availability of space, the Defense Health Board
meeting from 7 a.m. to 12 p.m. and from 2:15 p.m. to 5:15 p.m. on March
9, 2009 is open to the public. Any member of the public wishing to
provide input to the Defense Health Board should submit a written
statement in accordance with 41 CFR 102-3.140(C) and section 10(a)(3)
of the Federal Advisory Committee Act, and the procedures described in
this notice. Written statement should be not longer than two type-
written pages and must address the following detail: The issue,
discussion, and a recommended course of action. Supporting
documentation may also be included as needed to establish the
appropriate historical context and to provide any necessary background
information.
Individuals desiring to submit a written statement may do so
through the Board's Designated Federal Officer at the address detailed
above at any point. However, if the written statement is not received
at least 10 calendar days prior to the meeting, which is subject to
this notice, then it may not be provided to or considered by the
Defense Health Board until the next open meeting.
The Designated Federal Officer will review all timely submissions
with the Defense Health Board Chairperson, and ensure they are provided
to members of the Defense Health Board before the meeting that is
subject to this notice. After reviewing the written comments, the
Chairperson and the Designated Federal Officer may choose to invite the
submitter of the comments to orally present their issue during an open
portion of this meeting or at a future meeting.
The Designated Federal Officer, in consultation with the Defense
Health Board Chairperson, may, if desired, allot a specific amount of
time for members of the public to present their issues for review and
discussion by the Defense Health Board.
Dated: February 17, 2009.
Patricia L. Toppings,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. E9-3767 Filed 2-20-09; 8:45 am]
BILLING CODE 5001-06-P
